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Background: One of the promising applications of silk fibroin (SF) in biomedical engineering 
is its use as a scaffolding material for skin regeneration. The purpose of this study was to 
determine the wound healing effect of SF nanofibrous matrices containing silver sulfadiazine 
(SSD) wound dressings.
Methods: An SF nanofibrous matrix containing SSD was prepared by electrospinning. The 
cell attachment and spreading of normal human epidermal keratinocytes (NHEK) and normal 
human epidermal fibroblasts (NHEF) to SF nanofibers containing three different concentra-
tions of SSD contents (0.1, 0.5, and 1.0 wt%) were determined. In addition, a rat wound model 
was used in this study to determine the wound healing effect of SF nanofibers containing SSD 
compared with that of Acticoat™, a commercially available wound dressing.
Results: The number of NHEK and NHEF attached to SF nanofibers containing SSD decreased 
when the concentration of SSD increased. The number of attached NHEF cells was lower than 
that of attached NHEK cells. The SF matrix with 1.0 wt% SSD produced faster wound heal-
ing than Acticoat, although 1.0 wt% SSD inhibited the attachment of epidermal cells to SF 
nanofibers in vitro.
Conclusion: The cytotoxic effects of SF nanofibers with SSD should be considered in the 
development of silver-release dressings for wound healing through its antimicrobial activity. 
It is challenging to design wound dressings that maximize antimicrobial activity and minimize 
cellular toxicity.
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Introduction
The use of silver (Ag) as an antimicrobial agent has a long history.1 Since Moyer 
et al’s use of 0.5% silver nitrate (AgNO3) solution for patients with burns, use of Ag 
has resurged recently.2 Moyer proposed that AgNO3 solution did not interfere with 
epidermal proliferation, but possessed antibacterial properties against Staphylococcus 
aureus, Pseudomonas aeruginosa, and Escherichia coli.3,4 In 1968, AgNO3 was 
combined with sulfonamide to form silver sulfadiazine (SSD) cream, which served 
as an antibacterial agent with a broad spectrum of action. SSD cream, especially in 
the format of 1% cream, has been used for the treatment of burns.5
Among the various combinations of sulfa drugs with Ag tested in vitro, SSD 
appeared to be the most effective.6 SSD is effective against various bacteria, such as 
E. coli, S. aureus, Klebsiella species, and Pseudomonas species. SSD is also reported 
to possess some antifungal and antiviral activity.7
Ag can be effective against a wide range of micro-organisms, including aerobic 
and anaerobic bacteria, fungi, and viruses. The antimicrobial effect of Ag involves 
several mechanisms: it interferes with the respiratory chain in the cytochromes of 
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microbacteria;8 it interferes with components of the microbial 
electron transport system;9 and it binds DNA and inhibits 
DNA replication.10
Recently, there has been a rapid increase in the number 
of commercially available Ag dressings, such as AgNO3, 
SSD, and nanocrystalline Ag. Traditionally, the active Ag 
agent has been thought to be ionic Ag. However, elemental 
Ag was found to be active even when in a nanocrystal-
line form.11 It is possible to produce pure Ag particles at 
a nanometer scale with advanced nanotechnology. When 
cells or tissues are exposed to Ag nanoparticles (NPs), their 
active surface is significantly larger than that of other Ag 
compounds. As a result, Ag NPs are able to exhibit unusual 
physicochemical properties with remarkable biological activ-
ity. Ideal antimicrobial wound dressings should have more 
controlled and prolonged release of Ag compared with cream 
formulations during their entire period of usage. This will 
result in less frequent dressing changes, thereby reducing 
the risk of nosocomial infection, cost of care, further tissue 
damage, and patient discomfort. Many factors affect the clini-
cal performance of a dressing, such as the Ag content, the 
chemical and physical forms of Ag, the distribution of Ag, 
and its affinity for moisture.8,12 The number of commercially 
available Ag-based dressings has increased recently in the 
medical market.
Silk fibroin (SF) has been widely used for cosmetics and 
food additives. Recently, SF has been found to have potential 
in the area of biomedical science and engineering due to its 
distinctive biological properties, including biocompatibility, 
oxygen and water vapor permeability, biodegradability, and 
minimally induced inflammatory responses in vivo.13–16 One 
of the promising applications of SF in biomedical engineer-
ing is its use as a scaffolding material for skin regeneration. 
It was reported that SF could be useful for the culture of 
fibroblasts and keratinocytes, because it could enhance 
adhesion, growth, and differentiation of cells with benefits 
similar to those afforded by collagen matrices.17–19 In addi-
tion, nanofibrous scaffolds of biocompatible SF have great 
potential as dressings for burns wounds when combined 
with Ag compounds (eg, SSD) because they have a high 
specific surface area and microporous structure, and show 
good adhesion to damaged skin.
In this study, SF nanofibers containing SSD were pre-
pared as antimicrobial wound dressings. Re-epithelialization 
and wound contraction, the two important components in 
the process of wound healing, are mediated by keratinocytes 
and fibroblasts, respectively. Therefore, the cell attachment 
and spreading of normal human epidermal keratinocytes 
(NHEK) and normal human epidermal fibroblasts (NHEF) 
to the SF nanofibers containing SSD were determined in 
this study. The effect of SF nanofibers containing SSD on 
wound healing was compared with that of Acticoat™ in an 
animal wound model.
Materials and methods
Materials
Raw silk was obtained from the cocoons of the silkworm 
Bombyx mori. SSD (C10H9AgN4O2S; 99%) and formic acid 
(98%) were purchased from Sigma-Aldrich (St Louis, MO, 
USA) and Junsei (Tokyo, Japan), respectively. Calcium 
chloride and ethanol were purchased from Samcheon Chemi-
cals (Gyeonggi, Korea). Acticoat Ag-based dressings were 
purchased from Smith & Nephew (London, UK).
Preparation of electrospun SF nanofibers 
containing SSD
The raw silk fibers were degummed with 0.5 wt% sodium 
bicarbonate (NaHCO3) solution at 100°C for 30 minutes, fol-
lowed by rinsing with warm distilled water. The degummed 
silk (SF) was dissolved in a ternary solvent system of calcium 
chloride/ethanol/water (1/2/8 in molar ratio) at 70°C for 
4 hours. After dialysis in distilled water for 3 days in a cel-
lulose tubular membrane (molecular cutoff, 12,000–14,000), 
the aqueous SF solution was filtered and freeze-dried to 
obtain the regenerated SF sponge.
SF solution (8 wt%) was prepared by dissolving the 
regenerated SF sponge in 98% formic acid for 2 hours. Ag 
compounds were then added and dissolved in SF/formic 
acid solution for 1 hour. The concentrations of SSD were 
in the range of 0.1–1.0 wt% of the SF weight. The SF solu-
tion containing SSD was delivered using a syringe pump 
(KD Scientific, Holliston, MA, USA) at a flow rate of 
0.5 mL/hour. The distance between the needle tip and the 
ground electrode was 8 cm. The positive voltage applied 
to the polymer solutions was 16 kV. The electrospun SF 
nanofibers containing SSD were treated with water vapor in 
order to achieve solvent-induced crystallization of fibroin. 
The solvent-vapor treated samples were prepared by placing 
SF nanofiber matrices in a desiccator saturated with water 
vapor for 4 hours, followed by vacuum drying at room tem-
perature for 24 hours.
cells and cell culture
NHEK were prepared and maintained using a previously 
published procedure.18 Briefly, NHEK were isolated 
from human foreskin obtained surgically. The epidermal International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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keratinocytes were isolated from separated epithelial 
tissue after trypsinization. The primary cell cultures were 
established in a keratinocyte growth medium containing 
0.15 mM calcium and a supplementary growth-factor bullet 
kit. Primary NHEK were plated at 1×105 cells per 60 mm 
culture dish and cultured until the cells reached 70% con-
fluence. The second-passage keratinocyte cells were used 
in this study. 
Primary NHEF were established from the explant cultures 
of foreskin connective tissue, which was excised from a 
patient undergoing surgery. The cells that proliferated out-
wardly from the explant culture were cultured continuously 
in Dulbecco’s modified Eagle’s medium supplemented with 
10% fetal bovine serum. The third-passage fibroblast cells 
were used in this study.
All procedures used for sampling human tissue or 
specimens were performed in accordance with the guidelines 
of the institutional review board on human subject research, 
and the ethics committee at Seoul National University Dental 
Hospital, Seoul, Korea.
Cell attachment and spreading assays
The cell attachment assay was performed using the method 
reported by Mould et al with slight modifications.20 Briefly, 
SF nanofibers containing SSD were cut out with a punch 
(14 mm inner diameter) and placed onto 24-well cell culture 
plates. These plates were soaked in serum-free medium for 
30 minutes at room temperature, followed by rinsing with 
phosphate-buffered saline (PBS). The cells were detached 
from the culture plates by treatment with 0.05% trypsin 
and 0.53 mM ethylenediamine tetraacetic acid in PBS, and 
then resuspended in the culture medium. The cells were 
placed on the SF nanofibers containing SSD in each well 
at a density of 0.6×105 cells/250 μL and incubated at 37°C 
for 1 hour. The unattached cells were removed by rinsing 
twice with PBS. The attached cells were fixed with 10% 
formalin in PBS for 15 minutes and rinsed twice with PBS. 
The cells attached to the SF nanofibers containing SSD 
were stained with hematoxylin and eosin, and the wells 
were rinsed gently three times with double-distilled water. 
The SF nanofibers containing SSD were mounted and the 
cells attached to the matrix were photographed using an 
Olympus BX51 microscope.
The extent of cell spreading was analyzed using photo-
graphs obtained from the cell attachment assay. To ensure a 
representative count, each sample was divided into quarters, 
and two fields per quarter were photographed. The cells 
with a flattened, polygonal shape with filopodia-like and 
lamellipodia-like extensions were considered as spreading 
cells. In contrast, the cells that resisted washing and remained 
tethered to the plate surface were classified as nonspreading 
cells. Each spreading cell was determined using a computer 
equipped with CellProfiler cell image analysis software 
(Broad Institute, Cambridge, MA, USA). A minimum 
of 100 cells were counted on each occasion. The mean 
percentage and standard deviation were calculated from data 
obtained from four independent experiments. The percentage 
of cells showing a spreading morphology was quantified by 
dividing the number of spreading cells by the total number 
of bound cells.
animals 
Specific pathogen-free inbred male Sprague-Dawley (SD) 
rats, aged 7 weeks and routinely screened serologically for 
relevant respiratory pathogens, were purchased from Daehan 
Biolink Co Ltd (Seoul, Korea). Thirty-six SD rats were 
randomly divided into six groups, which were subjected 
to treatment with SF nanofibers only (no SSD; SF only), 
SF nanofibers containing 0.1 wt% SSD (SF/AgS 0.1), SF 
nanofibers containing 0.5 wt% SSD (SF/AgS 0.5), SF nano-
fibers containing 1.0 wt% SSD (SF/AgS 1.0), Acticoat, or no 
treatment (control). The rats were maintained and acclimated 
for 1 week in an animal facility under standard laboratory 
conditions for this study, with water and standard provided 
ad libitum. All experimental procedures were performed in 
accordance with the National Institutes of Health Guidelines 
for the Care and Use of Laboratory Animals, and the animals 
were handled according to the dictates of the National Animal 
Welfare Laws of Korea. 
Surgical procedures for wound healing 
test
The animals were anesthetized with an intramuscular injec-
tion of a mixture of Zoletil® 50 (Virbac, Carros, France) and 
Rompun® (Bayer Korea, Seoul, Korea; 150 cc/per rat). After 
anesthesia, the dorsal hair was carefully shaved. Four sites 
of full-thickness skin wounds above the fascia on the dorsal 
side of the rats were surgically created by a 6 mm diameter 
biopsy punch (Kai Industries, Seki, Japan). The wounds 
were treated with test dressings of SF only, SF/AgS 0.1, 
SF/AgS 0.5, SF/AgS 1.0, or Acticoat, and then covered with 
Tegaderm™ (3M, St Louis, MO, USA) to hold the dress-
ings in place. The wounds in the control group were covered 
with Tegaderm only. The wound dressings and covers were 
replaced at days 3, 7, and 14 post wounding until sacrifice 
or wound healing.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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assessment of wound closure
Wound closure was measured by a ruler and documented 
by digital photography before the animals were sacrificed 
at days 3, 7, and 14 post wounding. The wound healing rate 
was calculated as a percentage of the size of the unhealed 
wound area compared with the size of the initial dorsal 
wound area.
Histologic and histomorphometric 
procedures
At days 3, 7, and 14 post wounding, animals from each 
group were sacrificed with an overdose of a mixture of 
Zoletil 50 and Rompun. The original wound skins were 
harvested and fixed in 4% formalin overnight at 4°C. After 
fixation, the skins were embedded in paraffin and transversely 
cut into 5 mm thick slices, which were prepared with a 
microtome. Staining was performed using hematoxylin and 
eosin. Sections were analyzed using an optical microscope 
(Nikon, Tokyo, Japan) at 40× magnification. The extent of 
re-epithelialization of wounds was measured as the length 
of the line from the base of the dermis to the outlining of 
the epidermis from each section using the image analysis 
program (NIS-Elements, Nikon).
Results and discussion
Morphology of SF nanofibers containing 
ssD
The SF nanofibers containing SSD were fabricated by elec-
trospinning, and were composed of a randomly arranged 
fibrous structure, as shown in Figure 1A. The average fiber 
diameter of the SF only nanofibers was 379 nm, which 
was determined by image analysis of the scanning electron 
microscopic images (not shown). The addition of SSD to the 
SF solution caused a significant increase in the average fiber 
diameter to 512 nm (Figure 1B). Energy dispersive spectros-
copy analysis of the scanning electron microscopic images 
of SF nanofibers containing SSD is shown in Figure 1C. 
The elemental Ag and S in SSD were detected in the energy 
dispersive spectra.
Cytotoxic effect of SF nanofibers 
containing SSD on cell adhesion  
and spreading
In general, wounds produced in the dermis are healed by 
mechanisms involving re-epithelialization, construction, and 
matrix deposition. NHEK and NHEF both play important 
roles in the process of wound healing, because keratinocytes 
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and fibroblasts are the main cell types involved in produc-
tion of the dermal matrix.21 The initial cell attachment and 
spreading of the SF nanofibers containing Ag compounds 
were examined in this study because initial cell attachment 
and spreading may be important factors in the early stages 
of wound healing. To assess cell attachment, SF nanofibers 
containing SSD were seeded with NHEK and NHEF. The 
effect of SF nanofibers containing SSD on the attachment 
and spreading of NHEK is summarized in Figure 2. 
Representative images of NHEK attached to the SF nanofi-
bers containing SSD are shown in Figure 2A. A significantly 
(P0.05) high number of NHEK adhered to the SF only 
nanofibers than to SF in the presence of SSD (Figure 2B). 
The number of NHEK attached to SF nanofibers contain-
ing 1.0 wt% SSD was significantly lower than that to SF 
nanofibers containing 0.1 or 0.5 wt% SSD. When 1.0 wt% 
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SSD was added, it was too difficult for NHEK to attach to 
the SF nanofibers. The initial spreading of NHEK adhering 
to the SF nanofibers was similar in all groups, regardless of 
the SSD concentration (Figure 2C). Similarly, the number 
of NHEF attached to the SF nanofibers containing SSD was 
significantly (P0.05) lower than that attached to SF nanofi-
bers only (Figure 3). The initial spreading of NHEF adhering 
to the SF nanofibers containing SSD gradually decreased 
when SSD concentrations were increased (Figure 3C). Taken 
together, these results indicate that SF nanofibers containing 
SSD were cytotoxic to both NHEK and NHEF.
Skin wound healing effect of SF 
nanofibers containing SSD
Wound healing is a complex and multistep process involv-
ing the integration of a variety of tissue and cell types.22 
Re-epithelialization, a crucial process during the early 
phase of wound healing, occurs not only by the migration 
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and proliferation of keratinocytes in the epidermal layer of 
skin from the wound edge, but also by the differentiation 
of stem cells residing in the bulge of the hair follicles.23 
Rapid re-epithelialization following skin wounding pro-
vides an optimum environment for wound healing, includ-
ing a scaffold of cells and various growth factors that are 
indispensable for the wound healing process. Along with 
re-epithelialization, wound contraction plays a critical role 
in the early phase of wound healing by minimizing the 
open area through pulling the neighboring tissue toward 
the wound center. Alpha-smooth muscle actin generated 
from myofibroblasts plays a vital role in this process. 
Myofibroblasts arise by differentiation from fibroblasts 
and generate the force by which the wound area contracts 
during wound healing.24,25 Thus, intense research efforts 
are currently directed toward the development of new 
drugs and technologies to promote re-epithelialization and 
wound contraction.26
Acticoat, a wound dressing that employs nanocrystalline 
Ag technology, was reported to produce favorable results in 
an audit involving 70 burns patients who had few instances 
of cellulitis or antibiotic use.27 Other noncomparative studies 
have shown the safety and clinical benefits, such as less pain 
in burns patients using Acticoat wound dressings.28–30 When 
compared with topical antibiotic treatment in 20 patients 
who had meshed skin grafts, nanocrystalline Ag dressings 
have been shown to have an effect on epithelialization of 
their grafts.31
In the present study, wound healing effect between SF 
nanofibers containing SSD and Acticoat was compared using 
an SD rat model. Thirty-six SD rats were randomly divided 
into six groups of six rats each, which were subjected to the 
following six treatments: SF nanofibers only (no SSD; SF 
only), SF/AgS 0.1, SF/AgS 0.5, SF/AgS 1.0, Acticoat, or no 
treatment (control). The SD rat models treated by the surgical 
wounding protocol were photographed at days 3, 7, and 14 
post wounding. The wound appearance in rats at day 3 post 
treatment is shown in Figure 4.
The earliest histological change in the wound bed 
after wounding is wound contraction, a vital process for 
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minimizing the open wound area. Wound contraction is 
initiated by activated fibroblasts located at the wound edge, 
which differentiate into myofibroblasts that secrete actin and 
elastic fibers for wound contraction.26
At day 3 post surgery, limited wound healing without 
much wound contraction was observed in the controls (no 
Ag-based dressings). In contrast, those with Ag-based dress-
ings presented wound healing, with scabs generated in the 
wounds treated with SF/AgS 1.0 and Acticoat. At day 7 post 
surgery, the wound healing behavior differed significantly 
from that observed at day 3. All groups showed wound 
closing and regenerated epidermis. In addition, the sizes of 
wounds in rats treated with SF/AgS 1.0 and Acticoat were 
much smaller than those in rats from the other treatment 
groups. At day 14 post surgery, complete wound contrac-
tion occurred and the wounds were filled with regenerating 
skin similar to the original skin in all groups except the 
control group. Results for the wound closure rate according 
to time after wounding are summarized in Figure 5. The 
rate of wound closure in rats treated with SF nanofibers 
containing SSD was significantly (P0.05) higher than that 
in the control group. However, the wound healing ability 
of SF/AgS 1.0 was similar to that of Acticoat containing 
nanocrystalline Ag.
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Histological examination
The results for histological examination of epithelium 
taken from the wounds at days 3, 7, and 14 post wound-
ing are summarized in Figure 6. Hematoxylin and eosin 
staining showed that the epithelium at the edges of all 
wounds migrated toward the center. The histological 
morphology of wound healing was clearly observed at 
the wound margin by 3 days post wounding (Figure 6). 
At 3 days post wounding, the epidermis was regenerated 
in the wounds of the groups treated with SF/AgS 1.0 and 
Acticoat. At 7 days post wounding, regenerated epidermis 
was observed in all groups, and their dermal layers were 
thicker when compared with those at day 3 post wound-
ing. Wounds treated with SF/AgS 1.0 or Acticoat showed 
faster healing behavior than the other treatment groups. At 
14 days post wounding, the dermis and epidermis of the 
wounds was regenerated similar to that of the normal skin 
surrounding the wound. The extent of re-epithelialization 
in the wounds healed at 7 days post wounding for all six 
treatment groups is summarized in Figure 7. The extent 
of re-epithelialization of wounds treated with SF/AgS 0.5 
or SF/AgS 1.0 was significantly (P0.05) higher than in 
those treated with Acticoat. 
Conclusion
SF nanofibers containing SSD were prepared by electro-
spinning. The number of NHEK and NHEF attached to the 
SF nanofibers containing SSD decreased when the con-
centration of SSD increased, with the number of attached 
NHEF being lower than that of NHEK. In the animal study, 
the rate of wound closing was faster in rat treated with 
SSD containing a higher concentration of Ag. The wound 
healing effect of the SF nanofibers containing 1.0 wt% 
SSD was found to be comparable with that of Acticoat, 
a commercially available wound dressing. Therefore, the 
cytotoxic effects of SF nanofibers with SSD should be also 
considered in the development of Ag-release dressings for 
wound healing. It is a challenge to design wound dress-
ings that maximize antimicrobial activity and minimize 
cellular toxicity.
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Abbreviations: Ag, silver; SSD, silver sulfadiazine; SF, silk fibroin; AgS 0.1, 0.1 wt% 
SSD; AgS 0.5, 0.5 wt% SSD; AgS 1.0, 1.0 wt% SSD.
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